(S1 (S (NP (NP (NN RPS3)) (CC and) (NP (NN IKKbeta)) (NP (NN interaction)))))
(S1 (S (S (NP (NP (DT The) (NN activation)) (PP (IN of) (NP (NP (DT the) (NN inhibitor)) (PP (IN of) (NP (NP (NN kappaB) (NN kinase)) (PRN (-LRB- -LRB-) (NP (NN IKK)) (-RRB- -RRB-)))) (, ,) (VP (VBG consisting) (PP (IN of) (NP (DT a) (JJ regulatory) (NN subunit) (NP (NN IKKgamma)) (CC and) (NP (NP (CD two) (JJ catalytic) (NNS subunits)) (, ,) (NP (NP (NN IKKalpha)) (CC and) (NP (NN IKKbeta))) (, ,)))))))) (VP (VBZ is) (ADJP (JJ critical) (PP (IN for) (NP (NP (NP (DT the) (NP (NN phosphorylation)) (CC and) (NP (NN dispatch))) (PP (IN of) (NP (DT the) (JJ inhibitory) (NNS IkappaBs)))) (CC and) (NP (NP (DT the) (NN liberation)) (PP (IN of) (NP (NN NF-kappaB20-22))))))))) (. .)))
(S1 (S (PP (VBN Given) (SBAR (IN that) (S (NP (NN RPS3)) (VP (MD can) (VP (VB be) (VP (VBN found) (PP (IN in) (NP (NP (DT the) (JJ cytoplasmic) (NN p65-p50-IkappaBalpha) (JJ inhibitory) (NN complex)) (PP (IN in) (NP (VBG resting) (NNS cells6))))))))))) (, ,) (NP (PRP we)) (VP (VBD hypothesized) (SBAR (IN that) (S (NP (VBN activated) (NN IKKbeta)) (VP (MD might) (ADVP (RB also)) (VP (VP (VB bind) (PP (TO to))) (CC and) (VP (VB phosphorylate) (NP (NN RPS3)))))))) (. .)))
(S1 (S (ADVP (RB First)) (, ,) (NP (PRP we)) (VP (VBD found) (SBAR (IN that) (S (NP (ADJP (RB ectopically) (VBN expressed)) (NP (NP (NN IKKbeta)) (CC and) (NP (NN RPS3)))) (VP (VP (VBD interacted)) (-LRB- -LRB-) (NP (NNP Fig.) (CD 1c)) (-RRB- -RRB-))))) (. .)))
(S1 (S (S (NP (PRP We)) (ADVP (RB next)) (VP (VP (VP (VBD examined) (NP (VBG resting) (NN Jurkat) (NNS cells))) (CC and) (VP (VBD detected) (NP (DT a) (JJ modest) (JJ endogenous) (NN IKKbeta-RPS3) (NN interaction)))) (-LRB- -LRB-) (NP (NNP Fig.) (CD 1d)) (-RRB- -RRB-) (, ,) (S (ADVP (RB potentially)) (VP (VBG accounting) (PP (IN for) (NP (NP (DT the) (JJ basal) (NN NF-kappaB) (NN transcription)) (VP (VBN required) (PP (IN for) (NP (NP (NN cell) (NN proliferation)) (CC and) (NP (NN survival))))))))))) (. .)))
(S1 (S (S (NP (NN RPS3-IKKbeta) (NN association)) (VP (VBD was) (ADVP (RB clearly)) (VP (VBN augmented) (PP (IN upon) (NP (NN TNF) (NN stimulation))) (, ,) (S (VP (VBG peaking) (PP (IN at) (NP (CD 10) (NN min)))))))) (. .)))
(S1 (S (S (NP (-LRB- -LRB-) (NP (NNP Fig.) (CD 1d) (-RRB- -RRB-)) (, ,)) (VP (VBG following) (NP (JJ similar) (NNS kinetics)) (PP (TO to) (NP (NP (NN RPS3) (NN serine) (NN phosphorylation)) (PRN (-LRB- -LRB-) (NP (NNP Fig.) (NN 1b)) (-RRB- -RRB-)))))) (. .)))
(S1 (S (S (PP (IN By) (NP (NN contrast))) (, ,) (NP (EX there)) (VP (VBD was) (NP (NP (DT no) (JJ detectable) (NN interaction)) (PP (IN between) (NP (NP (NN RPS3)) (CC and) (NP (NN IKKalpha))))) (-LRB- -LRB-) (NP (NNP Fig.) (CD 1d)) (-RRB- -RRB-))) (. .)))
